2019 KSNO指南:成人WHO Ⅱ级脑胶质瘤

2019-10-07 国外神经外科相关专家小组(统称) Brain Tumor Res Treat. 2019 Oct;7(2):74-84.

2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅱ级脑胶质瘤指南,建议成人WHO Ⅱ级脑胶质瘤患者应根据肿瘤分子和组织学特点,通过最大程度的手术切除进行治疗,如果可行可在术后进行放疗和/或化疗。

中文标题:

2019 KSNO指南:成人WHO Ⅱ级脑胶质瘤

英文标题:

The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01.

发布日期:

2019-10-07

简要介绍:

2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅱ级脑胶质瘤指南,建议成人WHO Ⅱ级脑胶质瘤患者应根据肿瘤分子和组织学特点,通过最大程度的手术切除进行治疗,如果可行可在术后进行放疗和/或化疗。

 

拓展指南:胶质瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 KSNO指南:成人WHO Ⅱ级脑胶质瘤)] GetToolGuiderByIdResponse(projectId=1, id=58ca71c0018260ee, title=2019 KSNO指南:成人WHO Ⅱ级脑胶质瘤, enTitle=The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01., guiderFrom=Brain Tumor Res Treat. 2019 Oct;7(2):74-84., authorId=null, author=, summary=2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅱ级脑胶质瘤指南,建议成人WHO Ⅱ级脑胶质瘤患者应根据肿瘤分子和组织学特点,通过最大程度的手术切除进行治疗,如果可行可在术后进行放疗和/或化疗。 , cover=, journalId=null, articlesId=null, associationId=1328, associationName=国外神经外科相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 07 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅱ级脑胶质瘤指南,建议成人WHO Ⅱ级脑胶质瘤患者应根据肿瘤分子和组织学特点,通过最大程度的手术切除进行治疗,如果可行可在术后进行放疗和/或化疗。 </P> <P> </P>拓展指南:<strong>与<font color=red>胶质瘤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=108bb1c0018258c1" title="2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1)" target=_blank>2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6c8181c001e73386" title="中国老年胶质瘤患者术前评估专家共识(2019)" target=_blank>中国老年胶质瘤患者术前评估专家共识(2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3c0041c001e558a1" title="临床实践指南:成人弥漫性胶质瘤相关癫痫的诊断和治疗(英文版)" target=_blank>临床实践指南:成人弥漫性胶质瘤相关癫痫的诊断和治疗(英文版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=223d81c00168017a" title="脑胶质瘤诊疗规范(2018年版)" target=_blank>脑胶质瘤诊疗规范(2018年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cd64b1c001639674" title="唤醒状态下切除脑功能区胶质瘤手术技术指南(2018版)" target=_blank>唤醒状态下切除脑功能区胶质瘤手术技术指南(2018版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%83%B6%E8%B4%A8%E7%98%A4" target=_blank>有关胶质瘤更多指南</a></ul>, tagList=[TagDto(tagId=8810, tagName=脑胶质瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4767, appHits=260, showAppHits=13, pcHits=2572, showPcHits=2930, likes=50, shares=15, comments=3, approvalStatus=1, publishedTime=Tue Nov 12 23:45:17 CST 2019, publishedTimeString=2019-10-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 12 23:45:17 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:42:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 KSNO指南:成人WHO Ⅱ级脑胶质瘤)])
2019 KSNO指南:成人WHO Ⅱ级脑胶质瘤
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=918924, encodeId=30c19189245b, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbcc5430579, createdName=ms5000001054985728, createdTime=Fri Jan 22 08:59:06 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907076, encodeId=28f990e0760a, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3394687804, createdName=980580224, createdTime=Fri Dec 11 15:28:42 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2021-01-22 ms5000001054985728

    学习!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=918924, encodeId=30c19189245b, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbcc5430579, createdName=ms5000001054985728, createdTime=Fri Jan 22 08:59:06 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907076, encodeId=28f990e0760a, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3394687804, createdName=980580224, createdTime=Fri Dec 11 15:28:42 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2020-12-11 980580224

    厉害

    0